Allied Corp Increases Intellectual Property Protection by Filing Trademark for Pharma Product PSILONEX
KELOWNA, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Staff
Uber Eats and Nimble Announce On-Demand Prescription Delivery in Atlanta
Atlanta consumers can now request prescription delivery directly in the Uber Eats app. Uber’s prescription delivery is powered by Nimble,...
180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its...
Align Technology’s Invisalign Brand is the Official Smile Partner of U.S. Ski & Snowboard
U.S. Ski & Snowboard Athletes to Join the Invisalign Smile Squad Align Technology’s Invisalign Brand is the Official Smile Partner...
Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic Medicine Surges
NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Cybin Inc. (NEO: CYBN) today announces its placement in...
Aquestive Therapeutics Successfully Demonstrates Repeatable and Predictable Oral Sublingual Film Administration of Epinephrine
Provides in-depth scientific and clinical data in R&D event today at 9:00 am ETOutlines data from two completed Phase 1...
Albireo Announces First Patients Dosed in Two New Studies
– Dosed first patients in Phase 1 study with new product candidate A3907 – – First patient dosed in ASSERT...
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
BURLINGAME, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a...
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused...
Better Choice Announces Planned Expansion of Freeze-Dried Product Offerings Internationally to Support Strong Existing Distribution Partnerships in Asia
Freeze-dried raw dog food is one of the fastest growing sub-categories of the premium pet food marketNEW YORK, March 25,...
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Updates
Validive® Phase 2b/3 VOICE Clinical Trial CommencedCamsirubicin Phase 2 Clinical Trial Anticipated to Start in Q2 2021MNPR-101-Conjugate Data Published in...
Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results
– Company executing on growth strategy to build-out pipeline of development assets – Pivotal Phase 3 safety and efficacy study...
HMS Launches Coordination of Benefits on Demand Solution with Near Real-Time Insight into Other Coverage
Solution is part of HMS’ suite of innovative payment accuracy solutions used by more than 300 health plans and 40...
Sensei Biotherapeutics Reports Full Year 2020 Results and Provides Business Update
-Successfully completed upsized IPO in February 2021 raising approximately $152.6 million in gross proceeds – -Large subset of data expected from...
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
LEXINGTON, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents
MONTREAL, March 25, 2021 (GLOBE NEWSWIRE) -- A single dose of the Pfizer-BioNTech COVID-19 vaccine produces a much weaker antibody...
Zogenix to Participate in the Stifel 3rd Annual CNS Day
EMERYVILLE, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease...
Ayala Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Business Update
- Completed $25 Million Strategic Financing; Extending Cash Runway into 2023 - Accelerated Development of AL102 Desmoid Tumor Program into...
Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital
Funding to advance platform and portfolio of intranasal products that protect against a broad range of respiratory viruses, including influenza...
Shockwave Appoints Sara Toyloy to Board of Directors
SANTA CLARA, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...